🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of acetaminophen, asserting the firms concealed potential risks that the medication posed to pediatric cognitive development.

The court filing follows thirty days after President Donald Trump publicized an unverified association between using Tylenol - also known as paracetamol - during pregnancy and autism in young ones.

Paxton is filing suit against Johnson & Johnson, which formerly manufactured the medication, the sole analgesic recommended for pregnant women, and Kenvue, which presently makes it.

In a official comment, he stated they "betrayed America by making money from pain and marketing drugs ignoring the dangers."

The company states there is insufficient reliable data linking Tylenol to autism.

"These companies deceived for years, intentionally threatening millions to boost earnings," the attorney general, a Republican, stated.

The company commented that it was "deeply concerned by the dissemination of inaccurate information on the reliability of acetaminophen and the potential impact that could have on the health of US mothers and children."

On its online platform, the company also stated it had "regularly reviewed the pertinent research and there is insufficient valid information that indicates a proven link between using paracetamol and autism spectrum disorder."

Organizations acting on behalf of physicians and healthcare providers share this view.

The leading OB-GYN organization has said paracetamol - the key substance in Tylenol - is a restricted selection for expectant mothers to manage pain and elevated temperature, which can present major wellness concerns if left untreated.

"In over twenty years of research on the consumption of acetaminophen in gestation, zero credible investigations has definitively established that the usage of paracetamol in any trimester of gestation causes neurological conditions in offspring," the organization stated.

This legal action cites current declarations from the previous government in asserting the drug is allegedly unsafe.

In recent weeks, Trump generated worry from public health officials when he instructed pregnant women to "resist strongly" not to use acetaminophen when unwell.

Federal regulators then released a statement that medical professionals should contemplate reducing the use of Tylenol, while also mentioning that "a proven link" between the drug and autism in young ones has not been proven.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had promised in April to undertake "extensive scientific investigation" that would identify the cause of autism spectrum disorder in a short period.

But authorities warned that identifying a unique factor of autism spectrum disorder - believed by scientists to be the consequence of a intricate combination of genetic and environmental factors - would be difficult.

Autism spectrum disorder is a form of permanent neurological difference and disability that impacts how persons encounter and engage with the environment, and is diagnosed using physician assessments.

In his lawsuit, Paxton - who supports Trump who is seeking US Senate - asserts the manufacturer and Johnson & Johnson "deliberately disregarded and attempted to silence the science" around acetaminophen and autism.

The lawsuit aims to force the corporations "destroy any commercial messaging" that asserts Tylenol is secure for women during pregnancy.

The court case echoes the grievances of a assembly of guardians of children with autism and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in recently.

A federal judge rejected the case, declaring investigations from the family's specialists was lacking definitive proof.